Web
DirectoryNeuroGeneration: Neural Stem Cell Therapies Biotechnology for Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS
NeuroGeneration is a biotherapeutics company that develops new treatments and products for patients with neurological diseases, including Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS.
December 13, 2010
NeuroGeneration invited speaker at Shanghai's International Regenerative Medicine and Stem Cells..PRESS RELEASE
June 17, 2010
NeuroGeneration Paper Highlighed at International Parkinson's Society Meeting ....read more: PRESS RELEASE
March 1, 2010
US Patent issued to NeuroGeneration.The USPTO has issued a key patent for NeuroGeneration's ....read more: PRESS RELEASE
NeuroGeneration has been authorized by the FDA to conduct a phase II clinical trial for Parkinson's disease. This trial is currently on hold until we complete our cGMP processing center.
